🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

2,636 results for “-” Clear

  1. oxymetazoline hydrochloride

    UPNEEQ

    OPHTHALMIC FDA: approved

  2. oxymorphone hydrochloride

    OXYMORPHONE HYDROCHLORIDE Teva Pharma GmbH

    RECTAL FDA: approved

  3. oxyphencyclimine hydrochloride

    DARICON

    ORAL FDA: approved

  4. oxyphenonium bromide

    ANTRENYL

    ORAL FDA: approved

  5. oxytetracycline calcium

    TERRAMYCIN

    ORAL FDA: approved

  6. oxytetracycline hydrochloride

    TERRAMYCIN W/ POLYMYXIN

    ORAL FDA: approved

  7. ozanimod hydrochloride

    ZEPOSIA

    ORAL FDA: approved

  8. pabinafusp alfa

    IZCARGO

    PMDA: approved

  9. pacritinib citrate

    VONJO

    ORAL FDA: approved

  10. pafolacianine sodium

    CYTALUX

    INTRAVENOUS FDA: approved

  11. paliperidone palmitate

    PALIPERIDONE PALMITATE

    INTRAMUSCULAR FDA: approved

  12. palonosetron hydrochloride

    PALONOSETRON HYDROCHLORIDE Teva Pharma GmbH

    ORAL FDA: approved

  13. paltusotine hydrochloride

    PALSONIFY Crinetics Pharmaceuticals Europe GmbH

    ORAL FDA: approved

  14. pamidronate disodium

    PAMISOL Pfizer Australia Pty Ltd

    INJECTION FDA: approved · TGA: approved

  15. pancreas powder

    ENZEPI

    EMA: withdrawn

    A09AA02

  16. pancrelipase (amylase

    PERTZYE

    ORAL FDA: approved

  17. pancuronium bromide

    PANCURONIUM BROMIDE

    INJECTION FDA: approved

  18. pandemic influenza vaccine (h1n1) (split virion, inactivated, adjuvanted)

    HUMENZA

    EMA: withdrawn

    J07BB02

  19. pandemic influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted)

    AREPANRIX

    EMA: withdrawn

    J07BB02

  20. pandemic influenza vaccine (h5n1) (live attenuated, nasal)

    PANDEMIC INFLUENZA VACCINE H5N1 ASTRAZENECA (PREVIOUSLY PANDEMIC INFLUENZA VACCINE H5N1 MEDIMMUNE)

    EMA: approved

    J07BB03

  21. pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted)

    ADJUPANRIX (PREVIOUSLY PANDEMIC INFLUENZA VACCINE (H5N1) (SPLIT VIRION, INACTIVATED, ADJUVANTED) GLAXOSMITHKLINE BIOLOGICALS)

    EMA: approved

    J07BB02

  22. pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)

    FOCLIVIA

    EMA: approved

    J07BB02

  23. pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)

    INCELLIPAN

    EMA: approved

    J07BB02

  24. pandemic influenza vaccine (h5n1) (whole virion, inactivated, prepared in cell culture)

    PANDEMIC INFLUENZA VACCINE H5N1 BAXTER AG

    EMA: withdrawn

    J07BB01

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources